Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Maccalli

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Biomedicines|July 14, 2018
Immune Profiling of Cancer Patients Treated with Immunotherapy: Advances and ChallengesLorenzo Pilla, Cristina Maccalli
Oncoimmunology|November 20, 2012
The early antitumor immune response is necessary for tumor growth: Re-visiting Prehn's hypothesis in the human melanoma systemGiorgio Parmiani, Cristina Maccalli
Cancer Immunology, Immunotherapy : CII|August 9, 2014
Cancer stem cells: perspectives for therapeutic targetingCristina Maccalli, Ruggero De Maria
Immunological Investigations|March 14, 2017
Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of ImmunotherapyCristina Maccalli, Giorgio Parmiani, Soldano Ferrone
Expert Opinion on Biological Therapy|June 8, 2018
Methods for improving the immunogenicity and efficacy of cancer vaccinesLorenzo Pilla, Soldano Ferrone, Cristina Maccalli
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|November 24, 2019
The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with ImmunotherapyShilpa Ravindran, Saad Rasool, Cristina Maccalli
Cancer Immunology, Immunotherapy : CII|December 18, 2008
TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumorsCristina Maccalli, Samantha Scaramuzza, Giorgio Parmiani
Vaccines|September 8, 2015
Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of ImmunotherapyGiorgio Parmiani, Cristina Maccalli, Michele Maio
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Autologous versus allogeneic cell-based vaccines?Giorgio Parmiani, Lorenzo Pilla, Cristina Maccalli, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2013
Immunology of cancer stem cells in solid tumours. A reviewCristina Maccalli, Andrea Volontè, Carolina Cimminiello, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Biomedicines|July 14, 2018
Immune Profiling of Cancer Patients Treated with Immunotherapy: Advances and ChallengesLorenzo Pilla, Cristina Maccalli
Oncoimmunology|November 20, 2012
The early antitumor immune response is necessary for tumor growth: Re-visiting Prehn's hypothesis in the human melanoma systemGiorgio Parmiani, Cristina Maccalli
Cancer Immunology, Immunotherapy : CII|August 9, 2014
Cancer stem cells: perspectives for therapeutic targetingCristina Maccalli, Ruggero De Maria
Immunological Investigations|March 14, 2017
Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of ImmunotherapyCristina Maccalli, Giorgio Parmiani, Soldano Ferrone
Expert Opinion on Biological Therapy|June 8, 2018
Methods for improving the immunogenicity and efficacy of cancer vaccinesLorenzo Pilla, Soldano Ferrone, Cristina Maccalli
Cancer Microenvironment : Official Journal of the International Cancer Microenvironment Society|November 24, 2019
The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with ImmunotherapyShilpa Ravindran, Saad Rasool, Cristina Maccalli
Cancer Immunology, Immunotherapy : CII|December 18, 2008
TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumorsCristina Maccalli, Samantha Scaramuzza, Giorgio Parmiani
Vaccines|September 8, 2015
Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of ImmunotherapyGiorgio Parmiani, Cristina Maccalli, Michele Maio
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Autologous versus allogeneic cell-based vaccines?Giorgio Parmiani, Lorenzo Pilla, Cristina Maccalli, et al.
European Journal of Cancer (Oxford, England : 1990)|December 17, 2013
Immunology of cancer stem cells in solid tumours. A reviewCristina Maccalli, Andrea Volontè, Carolina Cimminiello, et al.
Pageof 6